25
Participants
Start Date
July 31, 2006
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Erlotinib hydrochloride
Patients will receive single-agent Tarceva, 150 mg/day
Sirolimus
Patients will receive a loading dose of 6 mg of Rapamune seven days after beginning treatment with Tarceva™ followed by a dose of 2mg/day.
University of Colorado Hospital, Aurora
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Colorado, Denver
OTHER